| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 24 | 2024 | 108 | 9.150 |
Why?
|
| Arginine | 27 | 2024 | 333 | 7.320 |
Why?
|
| Glutamine | 12 | 2018 | 215 | 3.170 |
Why?
|
| Urea | 13 | 2018 | 231 | 2.200 |
Why?
|
| Intestinal Mucosa | 9 | 2020 | 779 | 1.880 |
Why?
|
| Ornithine | 6 | 2012 | 31 | 1.810 |
Why?
|
| Arginase | 4 | 2020 | 32 | 1.740 |
Why?
|
| Nitrogen | 10 | 2017 | 146 | 1.600 |
Why?
|
| Gastrointestinal Tract | 4 | 2018 | 216 | 1.480 |
Why?
|
| Nutritional Requirements | 4 | 2017 | 181 | 1.450 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 7 | 2018 | 34 | 1.430 |
Why?
|
| Polyethylene Glycols | 4 | 2024 | 228 | 1.410 |
Why?
|
| Hydrolases | 4 | 2024 | 55 | 1.380 |
Why?
|
| Nitric Oxide | 8 | 2018 | 492 | 1.360 |
Why?
|
| Swine | 12 | 2024 | 1207 | 1.360 |
Why?
|
| Kidney | 8 | 2020 | 1366 | 1.280 |
Why?
|
| Nitrogen Isotopes | 8 | 2018 | 63 | 1.250 |
Why?
|
| Ornithine Carbamoyltransferase | 5 | 2018 | 17 | 1.150 |
Why?
|
| Phenylbutyrates | 4 | 2017 | 58 | 1.080 |
Why?
|
| Amino Acids | 6 | 2020 | 667 | 1.030 |
Why?
|
| Animals | 59 | 2024 | 34218 | 1.020 |
Why?
|
| Animals, Newborn | 10 | 2020 | 1016 | 1.020 |
Why?
|
| Diet | 6 | 2017 | 1140 | 0.830 |
Why?
|
| Mice | 34 | 2022 | 17632 | 0.800 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 256 | 0.790 |
Why?
|
| Cattle | 5 | 2007 | 569 | 0.770 |
Why?
|
| Mice, Inbred ICR | 7 | 2018 | 149 | 0.740 |
Why?
|
| Glycine | 2 | 2020 | 168 | 0.690 |
Why?
|
| Duodenum | 1 | 2020 | 99 | 0.670 |
Why?
|
| Jejunum | 1 | 2020 | 127 | 0.670 |
Why?
|
| Carbon Isotopes | 6 | 2017 | 277 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 4403 | 0.610 |
Why?
|
| Proline | 4 | 2012 | 78 | 0.600 |
Why?
|
| Endotoxins | 1 | 2018 | 48 | 0.590 |
Why?
|
| Dietary Supplements | 3 | 2017 | 473 | 0.580 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 77 | 0.570 |
Why?
|
| Benzoates | 1 | 2017 | 20 | 0.570 |
Why?
|
| Male | 40 | 2024 | 61463 | 0.550 |
Why?
|
| Growth | 1 | 2017 | 106 | 0.540 |
Why?
|
| Fetal Development | 1 | 2018 | 132 | 0.540 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 1006 | 0.530 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2020 | 243 | 0.510 |
Why?
|
| Hyperammonemia | 2 | 2006 | 62 | 0.500 |
Why?
|
| Dietary Proteins | 3 | 2014 | 252 | 0.500 |
Why?
|
| Aging | 2 | 2019 | 1184 | 0.500 |
Why?
|
| Sex Characteristics | 1 | 2017 | 313 | 0.490 |
Why?
|
| Biological Availability | 4 | 2021 | 137 | 0.470 |
Why?
|
| Intestines | 1 | 2018 | 577 | 0.450 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 93 | 0.450 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 48 | 0.450 |
Why?
|
| Muscle Proteins | 2 | 2015 | 417 | 0.430 |
Why?
|
| Intestine, Small | 4 | 2019 | 308 | 0.430 |
Why?
|
| Argininosuccinate Lyase | 4 | 2020 | 57 | 0.420 |
Why?
|
| Muscle, Skeletal | 3 | 2015 | 946 | 0.420 |
Why?
|
| Sus scrofa | 3 | 2020 | 128 | 0.410 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 25 | 0.400 |
Why?
|
| Membrane Transport Proteins | 2 | 2004 | 175 | 0.390 |
Why?
|
| Liver | 7 | 2018 | 1745 | 0.380 |
Why?
|
| Mice, Mutant Strains | 6 | 2018 | 384 | 0.380 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 238 | 0.380 |
Why?
|
| Ammonia | 6 | 2010 | 75 | 0.380 |
Why?
|
| Rumen | 4 | 2005 | 13 | 0.380 |
Why?
|
| Digestion | 3 | 2009 | 41 | 0.380 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2011 | 77 | 0.370 |
Why?
|
| Female | 32 | 2024 | 66747 | 0.370 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2018 | 187 | 0.370 |
Why?
|
| Mutation | 3 | 2018 | 5848 | 0.370 |
Why?
|
| Disease Models, Animal | 12 | 2024 | 4390 | 0.370 |
Why?
|
| Gestational Age | 2 | 2015 | 1161 | 0.370 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 49 | 0.360 |
Why?
|
| Models, Biological | 5 | 2014 | 1461 | 0.360 |
Why?
|
| Random Allocation | 5 | 2017 | 440 | 0.350 |
Why?
|
| Dipeptides | 3 | 2018 | 56 | 0.330 |
Why?
|
| Isotope Labeling | 3 | 2018 | 104 | 0.320 |
Why?
|
| Parenteral Nutrition | 4 | 2020 | 194 | 0.310 |
Why?
|
| Mice, Knockout | 8 | 2020 | 3742 | 0.310 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 330 | 0.310 |
Why?
|
| Models, Animal | 3 | 2020 | 464 | 0.300 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 78 | 0.300 |
Why?
|
| Argininosuccinic Aciduria | 4 | 2012 | 47 | 0.300 |
Why?
|
| Tumor Microenvironment | 3 | 2017 | 558 | 0.300 |
Why?
|
| Kinetics | 4 | 2021 | 1332 | 0.300 |
Why?
|
| Insulin Resistance | 3 | 2022 | 640 | 0.290 |
Why?
|
| Glutaredoxins | 2 | 2019 | 30 | 0.280 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 554 | 0.280 |
Why?
|
| Citric Acid Cycle | 3 | 2017 | 47 | 0.280 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 294 | 0.270 |
Why?
|
| Feces | 3 | 2005 | 727 | 0.270 |
Why?
|
| Glycolysis | 3 | 2017 | 150 | 0.270 |
Why?
|
| Animals, Laboratory | 1 | 2006 | 12 | 0.260 |
Why?
|
| Weaning | 2 | 2017 | 44 | 0.260 |
Why?
|
| Flow Injection Analysis | 1 | 2006 | 3 | 0.260 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 48 | 0.260 |
Why?
|
| Exosomes | 2 | 2017 | 44 | 0.250 |
Why?
|
| Phenylalanine | 4 | 2010 | 128 | 0.250 |
Why?
|
| Deuterium | 3 | 2017 | 109 | 0.250 |
Why?
|
| Liver Diseases | 3 | 2020 | 366 | 0.250 |
Why?
|
| Proteins | 1 | 2011 | 1036 | 0.250 |
Why?
|
| Urinalysis | 1 | 2006 | 61 | 0.240 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1024 | 0.230 |
Why?
|
| Catheterization | 1 | 2006 | 236 | 0.230 |
Why?
|
| Energy Metabolism | 3 | 2014 | 766 | 0.220 |
Why?
|
| Endotoxemia | 1 | 2024 | 58 | 0.220 |
Why?
|
| Sheep | 1 | 2004 | 220 | 0.220 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2010 | 52 | 0.210 |
Why?
|
| Glucose | 4 | 2022 | 877 | 0.200 |
Why?
|
| Short Bowel Syndrome | 2 | 2020 | 65 | 0.190 |
Why?
|
| Genotype | 4 | 2020 | 2561 | 0.190 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2014 | 150 | 0.190 |
Why?
|
| Neoplasms | 4 | 2017 | 2792 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 58 | 0.180 |
Why?
|
| Argininosuccinate Synthase | 2 | 2018 | 21 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 411 | 0.170 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 419 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 392 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2020 | 23 | 0.170 |
Why?
|
| Colitis | 2 | 2012 | 151 | 0.170 |
Why?
|
| Lactation | 2 | 2016 | 193 | 0.170 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 499 | 0.160 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2019 | 54 | 0.160 |
Why?
|
| Animal Feed | 2 | 2017 | 77 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 69 | 0.150 |
Why?
|
| Vasomotor System | 1 | 2018 | 25 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 193 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2019 | 135 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2312 | 0.140 |
Why?
|
| Animals, Domestic | 1 | 2017 | 31 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 133 | 0.140 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2016 | 11 | 0.140 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 156 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2019 | 3052 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 292 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 257 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 1287 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 187 | 0.130 |
Why?
|
| Species Specificity | 1 | 2017 | 550 | 0.130 |
Why?
|
| Cell Communication | 1 | 2017 | 166 | 0.130 |
Why?
|
| Fibroblasts | 3 | 2016 | 875 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 253 | 0.130 |
Why?
|
| Thinness | 1 | 2016 | 70 | 0.120 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 7 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2016 | 909 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2007 | 779 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 81 | 0.120 |
Why?
|
| Vitamin E | 1 | 2015 | 69 | 0.120 |
Why?
|
| Humans | 21 | 2020 | 125086 | 0.110 |
Why?
|
| Anabolic Agents | 1 | 2014 | 14 | 0.110 |
Why?
|
| Ligation | 1 | 2014 | 134 | 0.110 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2015 | 76 | 0.110 |
Why?
|
| Pregnancy | 4 | 2016 | 7194 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1241 | 0.110 |
Why?
|
| Blood Urea Nitrogen | 2 | 2004 | 74 | 0.110 |
Why?
|
| Alendronate | 1 | 2013 | 20 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 227 | 0.110 |
Why?
|
| Adult | 7 | 2017 | 29632 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 127 | 0.110 |
Why?
|
| Fracture Healing | 1 | 2013 | 28 | 0.110 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 64 | 0.110 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 481 | 0.110 |
Why?
|
| Nephrectomy | 1 | 2014 | 178 | 0.100 |
Why?
|
| Premature Birth | 1 | 2017 | 384 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 21 | 0.100 |
Why?
|
| Middle Aged | 5 | 2017 | 26926 | 0.100 |
Why?
|
| Inflammation | 4 | 2024 | 1444 | 0.100 |
Why?
|
| Thionucleosides | 1 | 2012 | 6 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2014 | 603 | 0.100 |
Why?
|
| Glycogenolysis | 1 | 2012 | 10 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 53 | 0.090 |
Why?
|
| Bone Density | 1 | 2014 | 319 | 0.090 |
Why?
|
| Dansyl Compounds | 1 | 2011 | 4 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 6 | 0.090 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 106 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 127 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 42 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 95 | 0.090 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2010 | 16 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 663 | 0.090 |
Why?
|
| Food Deprivation | 2 | 2012 | 32 | 0.090 |
Why?
|
| Methionine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Homocysteine | 1 | 2011 | 123 | 0.090 |
Why?
|
| Phenotype | 3 | 2018 | 4260 | 0.090 |
Why?
|
| Rats | 1 | 2017 | 3717 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 471 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2007 | 248 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 307 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1698 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 1288 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 682 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 235 | 0.080 |
Why?
|
| alpha-Glucosidases | 1 | 2009 | 28 | 0.080 |
Why?
|
| Starch | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 3349 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 683 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2521 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2012 | 687 | 0.070 |
Why?
|
| Germ-Free Life | 1 | 2007 | 60 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 308 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 186 | 0.070 |
Why?
|
| Mountaineering | 1 | 2006 | 2 | 0.070 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 157 | 0.060 |
Why?
|
| Altitude | 1 | 2006 | 23 | 0.060 |
Why?
|
| Insulin | 3 | 2022 | 1204 | 0.060 |
Why?
|
| Dietary Fiber | 2 | 2003 | 75 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1270 | 0.060 |
Why?
|
| Heart Failure | 1 | 2019 | 2297 | 0.060 |
Why?
|
| Maze Learning | 1 | 2006 | 128 | 0.060 |
Why?
|
| Fasting | 2 | 2022 | 293 | 0.060 |
Why?
|
| Environmental Pollution | 1 | 2005 | 13 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 82 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 702 | 0.060 |
Why?
|
| Enzymes | 1 | 2004 | 51 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 209 | 0.060 |
Why?
|
| Attention | 1 | 2006 | 202 | 0.060 |
Why?
|
| Urease | 1 | 2004 | 73 | 0.060 |
Why?
|
| Bacteria | 1 | 2007 | 484 | 0.050 |
Why?
|
| X-Ray Microtomography | 2 | 2014 | 85 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 19351 | 0.050 |
Why?
|
| Young Adult | 3 | 2012 | 9052 | 0.050 |
Why?
|
| Organ Size | 1 | 2004 | 436 | 0.050 |
Why?
|
| Memory | 1 | 2006 | 361 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2022 | 1563 | 0.050 |
Why?
|
| Energy Intake | 1 | 2005 | 494 | 0.050 |
Why?
|
| Creatinine | 1 | 2004 | 390 | 0.050 |
Why?
|
| Weight Loss | 1 | 2006 | 481 | 0.050 |
Why?
|
| Infant, Premature | 2 | 2020 | 817 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 47 | 0.050 |
Why?
|
| Milk | 1 | 2002 | 119 | 0.050 |
Why?
|
| Peroxidase | 2 | 2012 | 69 | 0.050 |
Why?
|
| Glutathione | 2 | 2014 | 194 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2054 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 1020 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1707 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2014 | 231 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2890 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2018 | 92 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2820 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 271 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 243 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 513 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2018 | 208 | 0.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 16 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1561 | 0.030 |
Why?
|
| Child | 3 | 2012 | 24384 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2016 | 4531 | 0.030 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 112 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 92 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 52 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 76 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2016 | 92 | 0.030 |
Why?
|
| Carbon | 1 | 2016 | 92 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1328 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 28 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 66 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1195 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 107 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 153 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 302 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 708 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 381 | 0.030 |
Why?
|
| Phytosterols | 1 | 2015 | 28 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2015 | 70 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 504 | 0.030 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2014 | 3 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8202 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fish Oils | 1 | 2015 | 84 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 50 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1103 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 459 | 0.030 |
Why?
|
| Metabolome | 1 | 2016 | 293 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2014 | 42 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 43 | 0.030 |
Why?
|
| Femur | 1 | 2014 | 67 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 625 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 154 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 867 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 173 | 0.030 |
Why?
|
| Bony Callus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 835 | 0.030 |
Why?
|
| Densitometry | 1 | 2013 | 25 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 30 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2014 | 154 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 19861 | 0.030 |
Why?
|
| Argininosuccinic Acid | 1 | 2012 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1696 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 466 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 878 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2012 | 101 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 245 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 28 | 0.020 |
Why?
|
| Placebos | 1 | 2012 | 241 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2012 | 14005 | 0.020 |
Why?
|
| Eating | 1 | 2014 | 367 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 49 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 618 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 14 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 229 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 315 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 345 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 187 | 0.020 |
Why?
|
| Body Composition | 1 | 2014 | 521 | 0.020 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 730 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 77 | 0.020 |
Why?
|
| Keto Acids | 1 | 2010 | 56 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 552 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 359 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 174 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 663 | 0.020 |
Why?
|
| Sucrase | 1 | 2009 | 22 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1169 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 88 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1638 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 522 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 304 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 423 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 55 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 2817 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2007 | 87 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2007 | 72 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 989 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 142 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1632 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1893 | 0.020 |
Why?
|
| Methylhistidines | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2757 | 0.020 |
Why?
|
| Alkalosis | 1 | 2006 | 24 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 57 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2006 | 62 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 66 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 3081 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2006 | 218 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1758 | 0.020 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2004 | 5 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 351 | 0.010 |
Why?
|
| Hyperargininemia | 1 | 2004 | 13 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4638 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 248 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3570 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 341 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 1016 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2006 | 220 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1329 | 0.010 |
Why?
|
| Carrier State | 1 | 2003 | 76 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12391 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2004 | 117 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2906 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2002 | 63 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1701 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 684 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1895 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 5175 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3299 | 0.010 |
Why?
|